Impact of oral probiotics on neurodevelopmental outcomes in preterm infants

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 30, Issue 4, 2017, Pages 411-415

  Akar, Melek ^a   Eras, Zeynep ^b   Oncel, Mehmet Yekta ^a   Arayici, Sema ^a   Guzoglu, Nilufer ^a   Canpolat, Fuat Emre ^a   Uras, Nurdan ^a   Oguz, Serife Suna ^a  

^a Division of Neonatology   (Turkey)

^b Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

Author keywords

Lactobacillus reuteri; neurodevelopmental outcome; preterm infant; probiotic

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; BAYLEY SCALES OF INFANT DEVELOPMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NERVOUS SYSTEM DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT; CHILD DEVELOPMENT; DIETARY SUPPLEMENT; ENTEROCOLITIS, NECROTIZING; INFANT, PREMATURE, DISEASES; NEURODEVELOPMENTAL DISORDERS; NEWBORN; PRESCHOOL CHILD;

CHILD DEVELOPMENT; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; ENTEROCOLITIS, NECROTIZING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MALE; NEURODEVELOPMENTAL DISORDERS; PROBIOTICS; PROSPECTIVE STUDIES;

EID: 84965006808     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767058.2016.1174683     Document Type: Article

References (33)

1. Deshpande G, Rao S, Patole S., Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight:a systematic review of randomised controlled trials. Lancet 2007;12:1614–20
2. Neu J, Walker WA., Necrotizing enterocolitis. N Engl J Med 2011;364:255–64
3. Ofek Shlomai N, Deshpande G, Rao S, Patole S., Probiotics for preterm neonates:what will it take to change clinical practice? Neonatology 2014;105:64–70
4. Sharma R, Hudak ML., A clinical perspective of necrotizing enterocolitis:past, present, and future. Clin Perinatol 2013;40:27–51
5. Millar M, Wilks M, Costeloe K., Probiotics for preterm infants? Arch Dis Child Fetal Neonatal Ed 2003;88:354–8
6. Orrhage K, Nord CE., Factors controlling the bacterial colonization of the intestine in breastfed infants. Acta Paediatr Suppl 1999;88:47–57
7. Duffy LC., Interactions mediating bacterial translocation in the immature intestine. J Nutr 2000;130:432–6
8. Dani C, Biadaioli R, Bertini G, et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002;82:103–8
9. Thompson AM, Bizzarro MJ., Necrotizing enterocolitis in newborns:pathogenesis, prevention and management. Drugs 2008;68:1227–38
10. Schulze SM, Deshpande GC, Patole SK., Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis:a systematic review of observational studies. Arch Pediatr Adolesc Med 2007;161:583–90
11. Smets K, Schwagten B., Postnatal cystic germinolysis and neonatal chronic lung disease:evaluation of risk factors and neurodevelopmental outcome. Acta Paediatr 2000;89:1111–4
12. Ann Wy P, Rettiganti M, Li J, et al. Impact of intraventricular hemorrhage on cognitive and behavioral outcomes at 18 years of age in low birth weight preterm infants. J Perinatol 2015;35:511–5
13. Imamura T, Ariga H, Kaneko M, et al. Neurodevelopmental outcomes of children with periventricular leukomalacia. Pediatr Neonatol 2013;54:367–72
14. Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates:a randomized study. Clin Infect Dis 2006;42:1735–42
15. Kitajima H, Sumida Y, Tanaka R, et al. Early administration of Bifidobacterium breve to preterm infants:randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 1997;76:101–7
16. Ehrenkranz RA, Dusick AM, Vohr BR, et al. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 2006;117:1253–61
17. Oncel MY, Sari FN, Arayici S, et al. Lactobacillus Reuteri for the prevention of necrotising enterocolitis in very low birthweight infants:a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2014;99:110–5
18. Bayley N., Bayley cales of infant development II. 2nd ed. Texas:John Wiley & Sons; 1993
19. Tomblin JB, Harrison M, Ambrose SE, et al. Language outcomes in young children with mild to severe hearing loss. Ear Hear 2015;1:76–91
20. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005;115:1–4
21. Bin-Nun A, Bromiker R, Wilscanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147:192–6
22. Casey PH, Whiteside-Mansell L, Barrett K, et al. Impact of prenatal and/or postnatal growth problems in low birth weight preterm infants on school-age outcomes:an 8-year longitudinal evaluation. Pediatrics 2006;118:1078–86
23. Neu J, Douglas-Escobar M, Lopez M. Microbes and the developing gastrointestinal tract. Nutr Clin Pract 2007;22:174–82
24. Caicedo RA, Schanler RJ, Li N, Neu J. The developing intestinal ecosystem:implications for the neonate. Pediatr Res 2005;58:625–8
25. Claud EC, Lu L, Anton PM, et al. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci USA 2004;101:7404–8
26. Ren Y, Lin CL, Li Z, et al. Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis. Histopathology 2005;46:659–67
27. De-Dooy JJ, Mahieu LM, Van Bever HP., The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 2001;160:457–63
28. Tauscher MK, Berg D, Brockmann M, et al. Association of histologic chorioamnionitis, increased levels of cord blood cytokines, and intracerebral hemorrhage in preterm neonates. Biol Neonate 2003;83:166–70
29. Bai AP, Ouyang Q, Zhang W, et al. Probiotics inhibit TNF-alpha-induced interleukin-8 secretion of HT29 cells. World J Gastroenterol 2004;10:455–7
30. Berger I, Peleg O, Ofeck-Sclomai N., Inflammation and early brain injury in term and preterm infants. Isr Med Assoc J 2012;14:318–23
31. Chou IC, Kuo HT, Chang JS, et al. Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants. J Pediatr 2010;156:393–6
32. Sari FN, Eras Z, Dizdar EA, et al. Do oral probiotics affect growth and neurodevelopmental outcomes in very low-birth-weight preterm infants? Am J Perinatol 2012;29:579–86
33. Howe TH, Sheu CF, Hsu YW, et al. Predicting neurodevelopmental outcomes at preschool age for children with very low birth weight. Res Dev Disabil 2016;48:231–41